BALFAXAR (human prothrombin complex concentrate-lans)
FACTOR IX · ANTICOAGULANT-INDUCED PROTHROMBIN DEFICIENCY
OCTAPHARMA USA
Drug class
Factor IX
Factor IX products constitute a therapeutic class of hemostatic clotting factor replacement therapies comprising human plasma-derived and recombinant coagulation proteins. Read more about Factor IX
10 drugs in this class 8 manufacturers
Drugs in Factor IX
Filter & compare in the drug finder →
Opens the drug finder with Factor IX preselected. Add indication or manufacturer filters there.
Factor IX products constitute a therapeutic class of hemostatic clotting factor replacement therapies comprising human plasma-derived and recombinant coagulation proteins.
They function by replenishing deficient or functionally absent intrinsic coagulation factor IX, which activates factor X in the blood clotting cascade to facilitate normal thrombin generation and stable fibrin clot formation.
This drug class is primarily indicated for the treatment, routine prophylaxis, and perioperative management of bleeding episodes in pediatric and adult patients with hemophilia B, also known as Christmas disease.
-
fda.gov
Factor IX products constitute a therapeutic class of hemostatic clotting factor replacement therapies comprising human plasma-derived and recombinant coagulation proteins
-
wfh.org
Factor IX products constitute a therapeutic class of hemostatic clotting factor replacement therapies comprising human plasma-derived and recombinant coagulation proteins
-
nih.gov
Factor IX products constitute a therapeutic class of hemostatic clotting factor replacement therapies comprising human plasma-derived and recombinant coagulation proteins
-
medlineplus.gov
They function by replenishing deficient or functionally absent intrinsic coagulation factor IX, which activates factor X in the blood clotting cascade to facilitate normal thrombin generation and stable fibrin clot formation
-
nih.gov
They function by replenishing deficient or functionally absent intrinsic coagulation factor IX, which activates factor X in the blood clotting cascade to facilitate normal thrombin generation and stable fibrin clot formation
-
fda.gov
This drug class is primarily indicated for the treatment, routine prophylaxis, and perioperative management of bleeding episodes in pediatric and adult patients with hemophilia B, also known as Christmas disease
-
fda.gov
This drug class is primarily indicated for the treatment, routine prophylaxis, and perioperative management of bleeding episodes in pediatric and adult patients with hemophilia B, also known as Christmas disease
-
bleeding.org
This drug class is primarily indicated for the treatment, routine prophylaxis, and perioperative management of bleeding episodes in pediatric and adult patients with hemophilia B, also known as Christmas disease
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.